View in EDS

Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II.

Saved in:
Bibliographic Details
Title: Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II.
Authors: Tzellos T; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Nordland Hospital Trust, Bodø, Norway., Giamarellos-Bourboulis EJ; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece., van Straalen KR; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands., Martorell A; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Hospital de Manises, Valencia, Spain., Kirby B; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; St Vincent's University Hospital, Elm Park and the Charles Institute, University College Dublin, Dublin, Ireland., Alavi A; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA., Hayama K; Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan., Khattri S; Department of Dermatology, The Mount Sinai Hospital, New York, New York, USA., Gulliver W; Newlab Clinical Research Inc., St John's, Newfoundland and Labrador, Canada., Sayed CJ; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Davis L; UCB, Morrisville, North Carolina, USA., Rolleri RL; UCB, Morrisville, North Carolina, USA., Crater C; UCB, Morrisville, North Carolina, USA., Pansar I; UCB, Brussels, Belgium., Lambert J; UCB, Colombes, France., Zouboulis CC; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Department of Venereology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Department of Allergology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Department of Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.
Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2026 Feb 14. Date of Electronic Publication: 2026 Feb 14.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41689425
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tzellos+T%22">Tzellos T</searchLink>; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Nordland Hospital Trust, Bodø, Norway.<br /><searchLink fieldCode="AU" term="%22Giamarellos-Bourboulis+EJ%22">Giamarellos-Bourboulis EJ</searchLink>; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22van+Straalen+KR%22">van Straalen KR</searchLink>; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Martorell+A%22">Martorell A</searchLink>; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Hospital de Manises, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Kirby+B%22">Kirby B</searchLink>; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; St Vincent's University Hospital, Elm Park and the Charles Institute, University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Alavi+A%22">Alavi A</searchLink>; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Hayama+K%22">Hayama K</searchLink>; Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Khattri+S%22">Khattri S</searchLink>; Department of Dermatology, The Mount Sinai Hospital, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Gulliver+W%22">Gulliver W</searchLink>; Newlab Clinical Research Inc., St John's, Newfoundland and Labrador, Canada.<br /><searchLink fieldCode="AU" term="%22Sayed+CJ%22">Sayed CJ</searchLink>; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Davis+L%22">Davis L</searchLink>; UCB, Morrisville, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Rolleri+RL%22">Rolleri RL</searchLink>; UCB, Morrisville, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Crater+C%22">Crater C</searchLink>; UCB, Morrisville, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Pansar+I%22">Pansar I</searchLink>; UCB, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Lambert+J%22">Lambert J</searchLink>; UCB, Colombes, France.<br /><searchLink fieldCode="AU" term="%22Zouboulis+CC%22">Zouboulis CC</searchLink>; European Hidradenitis Suppurativa Foundation (EHSF) e.V, Dessau, Germany.; Department of Dermatology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Department of Venereology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Department of Allergology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.; Department of Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229216037%22">Journal of the European Academy of Dermatology and Venereology : JEADV</searchLink> [J Eur Acad Dermatol Venereol] 2026 Feb 14. <i>Date of Electronic Publication: </i>2026 Feb 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9216037 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3083 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209269959%22">09269959 </searchLink><i>NLM ISO Abbreviation: </i>J Eur Acad Dermatol Venereol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41689425
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/jdv.70356
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tzellos T
      – PersonEntity:
          Name:
            NameFull: Giamarellos-Bourboulis EJ
      – PersonEntity:
          Name:
            NameFull: van Straalen KR
      – PersonEntity:
          Name:
            NameFull: Martorell A
      – PersonEntity:
          Name:
            NameFull: Kirby B
      – PersonEntity:
          Name:
            NameFull: Alavi A
      – PersonEntity:
          Name:
            NameFull: Hayama K
      – PersonEntity:
          Name:
            NameFull: Khattri S
      – PersonEntity:
          Name:
            NameFull: Gulliver W
      – PersonEntity:
          Name:
            NameFull: Sayed CJ
      – PersonEntity:
          Name:
            NameFull: Davis L
      – PersonEntity:
          Name:
            NameFull: Rolleri RL
      – PersonEntity:
          Name:
            NameFull: Crater C
      – PersonEntity:
          Name:
            NameFull: Pansar I
      – PersonEntity:
          Name:
            NameFull: Lambert J
      – PersonEntity:
          Name:
            NameFull: Zouboulis CC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 02
              Text: 2026 Feb 14
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1468-3083
          Titles:
            – TitleFull: Journal of the European Academy of Dermatology and Venereology : JEADV
              Type: main
ResultId 1